Zhengye Biotechnology (ZYBT) Stock Price, News & Analysis

Company Overview

Zhengye Biotechnology Holding Limited is a veterinary vaccine manufacturer which encompasses research, development, manufacturing and sales of veterinary vaccines, with a focus on livestock vaccine principally in China. Zhengye Biotechnology Holding Limited is based in Jilin, China.

Key Stats

• Today's Range: $4.70 to $5.67
• 50-Day Range: $4.03 to $8.20
• 52-Week Range: $3.70 to $10.00
• Volume: 226,583 shs
• Average Volume: 171,131 shs
• Market Capitalization: $241.02 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

ZYBT Stock Analysis - Frequently Asked Questions

How have ZYBT shares performed this year?

Zhengye Biotechnology's stock was trading at $4.86 at the beginning of the year. Since then, ZYBT shares have increased by 5.1% and is now trading at $5.11.
View the best growth stocks for 2025 here.

When did Zhengye Biotechnology IPO?

Zhengye Biotechnology (ZYBT) raised $6 million in an IPO on Tuesday, January 7th 2025. The company issued 1,500,000 shares at a price of $4.00 per share. Kingswood Capital Partners acted as the underwriter for the IPO.

When did Zhengye Biotechnology's quiet period expire?

Zhengye Biotechnology's quiet period expired on Monday, February 17th. Zhengye Biotechnology had issued 1,500,000 shares in its public offering on January 7th. The total size of the offering was $6,000,000 based on an initial share price of $4.00. During Zhengye Biotechnology's quiet period, insiders and underwriters that worked on the IPO were prevented from issuing any research reports or earnings estimates for the company because of regulations issued by the Securities and Exchange Commission. Now that the company's quiet period has ended, brokerages that served as underwriters are now able to initiate research on the company.

How do I buy shares of Zhengye Biotechnology?

Shares of ZYBT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Today: 3/31/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Pharmaceutical preparations
• Sub-Industry: Pharmaceutical Products
• Current Symbol: NASDAQ:ZYBT
• Previous Symbol: NASDAQ:ZYBT
• CIK: 1975641
• Web: www.jlzybio.com
• Phone: 86-13844801919
• Fax: N/A
• Employees: 278
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $189.75 million
• Price / Sales: 1.27
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 47,166,000
• Free Float: N/A
• Market Cap: $241.02 million
• Optionable: N/A
• Beta: N/A